The Best AI Show on Pharma
In a world where healthcare decisions are getting faster, smarter, and more complex, one force is quietly reshaping the entire pharma landscape: intelligence. Not the kind you read in reports, but the kind that emerges when data, science, and experience collide. The Best AI Show on Pharma steps right into that intersection. Hosted by Ayush Mishra, this podcast brings you candid, future-facing conversations with leaders who are redefining how medicines are discovered, developed, and delivered.
Each episode goes beyond buzzwords, beyond hype, and beyond surface-level talk. These are the real stories, the challenges no one admits, the breakthroughs no one sees coming, and the visions shaping the next decade of medicine. Whether you are a pharma professional, a healthcare innovator, or someone who believes that smarter technology can lead to better outcomes, this is where the future becomes understandable, practical, and actionable.
The Best AI Show on Pharma
Ep #1 | 80% of Trials Fail. Here's How AI Is Saving Billions for Pharma with Ayush Mishra ft. Dr. Scott Treiber
80% of clinical trials fail to recruit patients on time. This leads to massive financial losses and delays in getting life changing treatments to patients.
In this episode, Ayush Mishra sits down with Scott Treiber, COO of Cedar Health Research, to explore how modern technology and smarter workflows are transforming clinical research from the ground up.
You will hear insights on:
- Why clinical trials still move slowly and face major operational challenges
- How tools like Forge help clinics identify the right patients faster
- Real examples of improvements in recruitment and site productivity
- Which technologies in areas like AE monitoring, risk prediction and retention can impact patient outcomes the fastest
- How doctors, nurses and patients respond when new digital tools are introduced in everyday practice
- The biggest misconceptions and risks that still hold the industry back
- What the next five years of clinical research could look like with the right adoption
If you work in pharma, clinical operations, site networks, or research strategy, this conversation offers a clear view of where the future of trials is headed.
Scott Treiber's LinkedIn: https://www.linkedin.com/in/streiber/
Ayush Mishra's LinkedIn: https://www.linkedin.com/in/ayushmishra/
